BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26280510)

  • 1. Whole-Genome Sequencing of Growth Hormone (GH)-Secreting Pituitary Adenomas.
    Välimäki N; Demir H; Pitkänen E; Kaasinen E; Karppinen A; Kivipelto L; Schalin-Jäntti C; Aaltonen LA; Karhu A
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3918-27. PubMed ID: 26280510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.
    Ronchi CL; Peverelli E; Herterich S; Weigand I; Mantovani G; Schwarzmayr T; Sbiera S; Allolio B; Honegger J; Appenzeller S; Lania AG; Reincke M; Calebiro D; Spada A; Buchfelder M; Flitsch J; Strom TM; Fassnacht M
    Eur J Endocrinol; 2016 Mar; 174(3):363-72. PubMed ID: 26701869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel somatic variants involved in biochemical activity of pure growth hormone-secreting pituitary adenoma without GNAS variant.
    Ku CR; Lim H; Lee YJ; Kim SH; Kim D; Kim SH; Lee MK; Bang D; Lee EJ
    Sci Rep; 2021 Aug; 11(1):16530. PubMed ID: 34400688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and Epigenetic Characterization of Growth Hormone-Secreting Pituitary Tumors.
    Välimäki N; Schalin-Jäntti C; Karppinen A; Paetau A; Kivipelto L; Aaltonen LA; Karhu A
    Mol Cancer Res; 2019 Dec; 17(12):2432-2443. PubMed ID: 31578227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of major genetic factors involved in pituitary tumorigenesis and their impact on clinical and biological characteristics of sporadic somatotropinomas and non-functioning pituitary adenomas.
    Foltran RK; Amorim PVGH; Duarte FH; Grande IPP; Freire ACTB; Frassetto FP; Dettoni JB; Alves VA; Castro I; Trarbach EB; Bronstein MD; Jallad RS
    Braz J Med Biol Res; 2018 Jun; 51(9):e7427. PubMed ID: 29947650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission.
    Freda PU; Chung WK; Matsuoka N; Walsh JE; Kanibir MN; Kleinman G; Wang Y; Bruce JN; Post KD
    Pituitary; 2007; 10(3):275-82. PubMed ID: 17594522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Alterations and Complex Subclonal Architecture in Sporadic GH-Secreting Pituitary Adenomas.
    Hage M; Viengchareun S; Brunet E; Villa C; Pineau D; Bouligand J; Teglas JP; Adam C; Parker F; Lombès M; Tachdjian G; Gaillard S; Chanson P; Tosca L; Kamenický P
    J Clin Endocrinol Metab; 2018 May; 103(5):1929-1939. PubMed ID: 29474559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylator Phenotype and Ectopic GIP Receptor in GNAS Mutation-Negative Somatotropinomas.
    Hage M; Chaligné R; Viengchareun S; Villa C; Salenave S; Bouligand J; Letouzé E; Tosca L; Rouquette A; Tachdjian G; Parker F; Lombès M; Lacroix A; Gaillard S; Chanson P; Kamenický P
    J Clin Endocrinol Metab; 2019 May; 104(5):1777-1787. PubMed ID: 30376114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.
    Occhi G; Losa M; Albiger N; Trivellin G; Regazzo D; Scanarini M; Monteserin-Garcia JL; Fröhlich B; Ferasin S; Terreni MR; Fassina A; Vitiello L; Stalla G; Mantero F; Scaroni C
    J Neuroendocrinol; 2011 Jul; 23(7):641-9. PubMed ID: 21554434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GH/PRL-secreting pituitary macroadenoma associated with GNAS p.Gln227Leu mutation: pediatric case report and review.
    Watanabe D; Yagasaki H; Kojika S; Ogiwara M; Kinouchi H; Nakane T; Inukai T
    Endocr J; 2019 May; 66(5):403-408. PubMed ID: 30814395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
    Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-Exome Sequencing Study of Thyrotropin-Secreting Pituitary Adenomas.
    Sapkota S; Horiguchi K; Tosaka M; Yamada S; Yamada M
    J Clin Endocrinol Metab; 2017 Feb; 102(2):566-575. PubMed ID: 27854551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of pituitary adenomas.
    Gadelha MR; Trivellin G; Hernández Ramírez LC; Korbonits M
    Front Horm Res; 2013; 41():111-40. PubMed ID: 23652674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome.
    Vortmeyer AO; Gläsker S; Mehta GU; Abu-Asab MS; Smith JH; Zhuang Z; Collins MT; Oldfield EH
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2404-13. PubMed ID: 22564667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
    Xu T; Ye F; Wang B; Tian C; Wang S; Shu K; Guo D; Lei T
    Neuro Endocrinol Lett; 2010; 31(1):147-54. PubMed ID: 20150876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic Deletion in Exon 10 of Aryl Hydrocarbon Receptor Gene in Human GH-Secreting Pituitary Tumors.
    Re A; Ferraù F; Cafiero C; Spagnolo F; Barresi V; Romeo DP; Ragonese M; Grassi C; Pontecorvi A; Farsetti A; Cannavò S
    Front Endocrinol (Lausanne); 2020; 11():591039. PubMed ID: 33281746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of AIP and inhibitory G protein alpha 2 proteins on clinical features of sporadic GH-secreting pituitary adenomas.
    Ritvonen E; Pitkänen E; Karppinen A; Vehkavaara S; Demir H; Paetau A; Schalin-Jäntti C; Karhu A
    Eur J Endocrinol; 2017 Feb; 176(2):243-252. PubMed ID: 27998919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and clinical characteristics of Japanese patients with sporadic somatotropinoma.
    Matsumoto R; Izawa M; Fukuoka H; Iguchi G; Odake Y; Yoshida K; Bando H; Suda K; Nishizawa H; Takahashi M; Inoshita N; Yamada S; Ogawa W; Takahashi Y
    Endocr J; 2016 Nov; 63(11):953-963. PubMed ID: 27498687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
    Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Genetic Causes of Pituitary Adenomas.
    Caimari F; Korbonits M
    Clin Cancer Res; 2016 Oct; 22(20):5030-5042. PubMed ID: 27742789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.